Answers are grounded in this paper and cite their sources.
The modulation of gene regulation by blocking the interaction between the thyroid receptor (TR) and obligate coregulators has been reported recently with the discovery of the lead compound 3-(dimethylamino)-1-(4-hexylphenyl)propan-1-one). Herein we report studies aimed at optimization of this initial hit to determine the basic parameters of the structure-activity relationships and clarify the mechanism of action. These studies provided new insights, showing that activity and TRbeta isoform selectivity is highly correlated with the structural composition of these covalent inhibitors.
No takes yet. Share an insight, caveat, or question.
Arnold et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: